ARDT vs TECH · P/E 8.5, rev $5.97B vs P/E 65, rev $1.22B
Ardent Health Partners, Inc. (ARDT) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Ardent Health Partners, Inc. (ARDT) is a medical care facilities company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported ARDT revenue for 2024-12-31 was $5.97B. Net income was $299.7M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. ARDT currently screens at market cap $2.10B and trailing P/E 8.5.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
ARDT currently screens at market cap $2.10B and trailing P/E 8.5. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the ARDT and TECH stock pages for the full models.
Not investment advice.